IP Library Granted Patent US 10,258,809
Granted Patent B2
US 10,258,809 · App. 15/137,748 · Granted Apr 16, 2019

Systems and methods for photoactivating a photosensitizer applied to an eye

Inventors: Marc D. Friedman (Needham, MA); Mikhail Smirnov (North Andover, MA); Pavel Kamaev (Lexington, MA)
Assignee: Avedro, Inc.
A61N5/0624A61F9/029A61N5/062A61M2202/0208A61M2205/3368A61M2205/36A61M2205/52A61M2210/0612A61N2005/0626A61N2005/0648A61N2005/0661
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,258,809
App. No.
15/137,748
Granted
Apr 16, 2019
Kind
B2
Abstract

An antimicrobial treatment system comprises a wearable photoactivation device. The wearable photoactivation device includes a body configured to be positioned on a head of a subject over one or more eyes of the subject. The body includes one or more windows or openings that allow the one or more eyes to see through the body. The body includes one or more photoactivating light sources coupled to the body and configured to direct photoactivating light to the one or more eyes according to illumination parameters. The illumination parameters determine a dose of the photoactivating light that activates, according to photochemical kinetic reactions, a photosensitizer applied to the one or more eyes and generates reactive oxygen species that provide an antimicrobial effect in the one or more eyes, without substantially inducing cross-linking activity that produces biomechanical changes in the one or more eyes.

Claims (18)

1. An antimicrobial treatment system comprising a wearable photoactivation device including:

a body defining a chamber shaped to be positioned over and enclose one or more eyes of a subject, the body including one or more windows that allow the one or more eyes to see through the body;

one or more photoactivating light sources coupled to the body and configured to direct photoactivating light to the one or more eyes according to illumination parameters, the illumination parameters determining a dose of the photoactivating light that activates, according to photochemical kinetic reactions, a photosensitizer applied to the one or more eyes and generates reactive oxygen species that provide an antimicrobial effect in the one or more eyes; and

an inlet configured to couple the body to an oxygen source, the chamber receiving oxygen from the oxygen source via the inlet to modify oxygen conditions in the chamber, the activation of the photosensitizer depending on the oxygen conditions.

2. The antimicrobial treatment system of claim 1 , wherein the one or more photoactivating light sources deliver the photoactivating light as at least one of pulses or continuous wave, and the illumination parameters include at least one of wavelength, power, irradiance, intensity, duration, or duty cycle.

3. The antimicrobial treatment system of claim 1 , wherein the photosensitizer includes riboflavin, the one or more photoactivating light sources deliver ultraviolet light.

4. The antimicrobial treatment system of claim 3 , wherein the dose of the photoactivating light activates the photosensitizer and generates reactive oxygen species that provide the antimicrobial effect in the one or more eyes, without inducing cross-linking activity that produces biomechanical changes in the one or more eyes.

5. The antimicrobial treatment system of claim 1 , further comprising a controller including one or more processors and one or more computer readable media, the one or more processors configured to execute instructions from the computer readable media to:

determine the illumination parameters based on a model of the photochemical kinetic reactions; and

operate the one or more photoactivating light sources according to the illumination parameters.

6. The antimicrobial treatment system of claim 1 , wherein the photoactivation device further includes one or more heating elements coupled to the body and configured to generate heat in the chamber according to temperature parameters, the temperature parameters modifying, according to the photochemical kinetic reactions, the activation of the photosensitizer applied to the one or more eyes and the generation of reactive oxygen species that provide the antimicrobial effect in the one or more eyes.

7. The antimicrobial treatment system of claim 6 , further comprising a controller including one or more processors and one or more computer readable media, the one or more processors configured to execute instructions from the computer readable media to:

determine the temperature parameters based on a model of the photochemical kinetic reactions; and

operate the one or more heating elements according to the temperature parameters.

8. The antimicrobial treatment system of claim 1 , wherein the oxygen from the oxygen source modifies a temperature in the chamber according to temperature parameters, the temperature parameters modifying, according to the photochemical kinetic reactions, the activation of the photosensitizer applied to the one or more eyes and the generation of reactive oxygen species that provide the antimicrobial effect in the one or more eyes.

9. The antimicrobial treatment system of claim 8 , further comprising a controller including one or more processors and one or more computer readable media, the one or more processors configured to execute instructions from the computer readable media to:

determine the temperature parameters based on a model of the photochemical kinetic reactions; and

operate the oxygen source according to the temperature parameters.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Nov 21, 2019
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: AVEDRO, INC.
Reel/Frame 051080/0756 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL NO. 14/140,184 PREVIOUSLY RECORDED AT REEL: 042167 FRAME: 0671. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 1, 2017
From: AVEDRO, INC.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042390/0659 →
SECURITY INTEREST Recorded Apr 27, 2017
From: AVEDRO, INC.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042167/0671 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2016
From: SMIRNOV, MIKHAIL
To: AVEDRO, INC.
Reel/Frame 039917/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2016
From: FRIEDMAN, MARC D.
To: AVEDRO, INC.
Reel/Frame 039917/0133 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2016
From: KAMAEV, PAVEL
To: AVEDRO, INC.
Reel/Frame 039915/0074 →
Continuity (4)
Provisional Application 62279951 · Jan 18, 2016
Provisional Application 62152568 · Apr 24, 2015
Provisional Application 62152533 · Apr 24, 2015
Related Publication 20160310758A1 · Oct 27, 2016
Cited By (2)
US 12,214,039 US 12,472,376